A new study from the University of Wisconsin-Madison shows current anti-COVID-19 pills work well against the Omicron variant, but antibody drugs are less effective. Researchers at the UW School of Veterinary Medicine found the Omicron variant has so many different mutations in spike proteins that antibody treatments can’t keep up.
Office of Strategic Communication